"Red Maple Trials provides specialty services in allergy, asthma, and immunology clinical research in Canada. Our experienced team and state-of-the-art facilities are redefining allergy and immunology clinical research—bringing promising new therapies to the patients who need them."

During the past decade, Red Maple Trials conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Red Maple Trials" are "COVID-19" (2 trials), "Coronavirus Infections" (2 trials) and "Allergic Rhinitis Due to Cat Allergy" (1 trials). Many other conditions were trialed in "Red Maple Trials" in a lesser frequency.

Most popular intervention types in "Red Maple Trials" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Matching Placebo" (1 trials), "REGN1908-1909" (1 trials), "VBI-2901a" (1 trials) and "VBI-2901e" (1 trials). Other intervention names were less common.

The vast majority of trials in "Red Maple Trials" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Red Maple Trials". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Red Maple Trials, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Red Maple Trials, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".